Oberscherli, Switzerland

Christoph Aebi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Csl Behring Ag, Universitaet Bern. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christoph Aebi. Retrieved from https://idiyas.com/inventor/christoph-aebi-uam7fqph

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christoph Aebi: Innovator in Mucositis Treatment

Introduction

Christoph Aebi is a notable inventor based in Oberscherli, Switzerland. He has made significant contributions to the field of medical treatment, particularly in addressing mucositis, a painful condition often resulting from cancer therapies.

Latest Patents

Aebi holds a patent for the "Treatment of mucositis with immunoglobulin." This invention relates to compositions that comprise immunoglobulin for use in the treatment of mucositis through topical application. Specifically, it focuses on compositions that include J chain-containing IgA and secretory component for effective treatment.

Career Highlights

Throughout his career, Christoph Aebi has worked with prominent organizations, including CSL Behring AG and the University of Bern. His work in these institutions has allowed him to advance his research and contribute to innovative solutions in healthcare.

Collaborations

Aebi has collaborated with notable colleagues such as Sonja Christina Lueer and Alexander Schaub. These partnerships have played a crucial role in enhancing his research and development efforts.

Conclusion

Christoph Aebi's work in the treatment of mucositis showcases his dedication to improving patient care through innovative solutions. His contributions to the field are significant and reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…